Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q92698132 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241221010740.0 | ||
| 008 | 241221nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q92698132 | ||
| 024 | ‡a 0000-0002-4731-7588 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q92698132 | ||
| 100 | 0 | ‡a Reeba John ‡c researcher (ORCID 0000-0002-4731-7588) ‡9 en | |
| 400 | 0 | ‡a Reeba John ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's Outcomes analysis in patients with extended-spectrum beta-lactamase bacteremia empirically treated with piperacillin/tazobactam versus carbapenems | ||
| 909 | ‡a (orcid) 0000000247317588 ‡9 1 | ||
| 919 | ‡a outcomesanalysisinpatientswithextendedspectrumbetalactamasebacteremiaempiricallytreatedwithpiperacillintazobactamversuscarbapenems ‡A Outcomes analysis in patients with extended-spectrum beta-lactamase bacteremia empirically treated with piperacillin/tazobactam versus carbapenems ‡9 1 | ||
| 996 | ‡2 J9U|987012500826105171 | ||
| 996 | ‡2 J9U|987007366976605171 | ||
| 996 | ‡2 LC|no2013112151 | ||
| 996 | ‡2 ISNI|0000000084015568 | ||
| 996 | ‡2 LC|no2009053164 | ||
| 996 | ‡2 J9U|987010649807905171 | ||
| 996 | ‡2 DNB|126505241 | ||
| 996 | ‡2 RERO|A003427284 | ||
| 996 | ‡2 DNB|1065344074 | ||
| 996 | ‡2 DNB|1155764552 | ||
| 996 | ‡2 LC|no2019017320 | ||
| 996 | ‡2 BIBSYS|90301299 | ||
| 996 | ‡2 LC|no2022067935 | ||
| 996 | ‡2 DNB|126505233 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
